1. Home
  2. RENX vs BGLC Comparison

RENX vs BGLC Comparison

Compare RENX & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$1.70

Market Cap

4.1M

Sector

N/A

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.28

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
BGLC
Founded
2021
2017
Country
United States
Malaysia
Employees
38
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RENX
BGLC
Price
$1.70
$2.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
278.3K
6.1K
Earning Date
05-22-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$1.92
52 Week High
$3.48
$15.19

Technical Indicators

Market Signals
Indicator
RENX
BGLC
Relative Strength Index (RSI) 44.33 58.33
Support Level $1.40 $2.14
Resistance Level $2.21 $2.73
Average True Range (ATR) 0.17 0.11
MACD -0.04 0.04
Stochastic Oscillator 38.27 69.15

Price Performance

Historical Comparison
RENX
BGLC

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: